|1||NCT02365831||Recruiting||Observation of Medical Treatments in MBC HER2-negative Patients||
||Other / Industry||
||1500||Female||18 Years and older (Adult, Senior)||NCT02365831||GIM13-AMBRA||AMBRA||May 2015||December 2016||December 2017||February 19, 2015||June 15, 2016||
|Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer||
||Industry / Other||
||5099||Female||18 Years and older (Adult, Senior)||NCT00045032||BO16348
|HERA||November 2001||March 2005||June 2015||January 27, 2003||April 27, 2017||April 27, 2017||
† Study has passed its completion date and status has not been verified in more than two years.